logo-loader
viewMarrone Bio Innovations

Marrone Bio Innovations sets record in Q-3 financials

Marrone Bio Innovatons (MBII-NASDAQ) CEO Marrone joined Steve Darling from Proactive Investors at the LD MIcro Show in Los Angeles to talk about the success her company has seen especially in Q-3. That success has come from some changes and some key hiring. The company is a a leading provider of bio-based pest management. Dr Marrone also told Proactive about two major awards the company won this year. 

Quick facts: Marrone Bio Innovations

Price: 1.12 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $149.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Marrone Bio Innovations CCO reveals highlights from the...

Marrone Bio Innovations Inc (NASDAQ:MBII) Chief Commercialization Officer Kevin Hammill revealed to Proactive results from recent yield and stress tolerance trials presented at the “Exceed The Seed” event during the recent American Seed Trade Association meeting in Chicago. Hammill says...

8 hours, 9 minutes ago

2 min read